Acambis warns of delay in US contract
Tuesday 26 November 2002
Acambis, the biotech group whose fortunes were transformed by orders for a smallpox vaccine, admitted yesterday that it has suffered delays to its flagship contract to supply the US government.
The disappointment overshadowed news that the company has signed two more contracts with countries concerned about the threat of a bioterrorist attack.
Some £25m of revenue that had been expected to come through before Christmas will now be delayed into next year, after Acambis found itself unable to carry out the necessary testing on batches of the smallpox vaccine, which is made from cowpox.
John Brown, the chief executive, said: "We had a shortage of a chemical agent used in the testing, so we had the product backed up waiting to be tested. The revenue of $428m [£273m] from the contract is staying the same, the margins are staying the same, but some of the money that we said would come in during the fourth quarter of this year will now come in during the first quarter of next year."
The news sent Acambis shares down more than 10 per cent in early trading, but they recovered to close off only 4 per cent at 250.5p as analysts maintained their bullish stance. Nomura had been forecasting a maiden profit of £8.1m for 2002, and while that has now been reduced to £1.6m, the 2003 profit figure has grown from £27.7m to £36.1m.
Mr Brown refused to identify the two countries who have signed contracts for the supply of smallpox vaccine, but said they would be "small in comparison" with the US deal. Analysts expect revenues will be in "single-figure millions" of dollars.
A third country, Austria, has signalled its intention to buy smallpox vaccine from Acambis, but it is yet to sign a deal.
The US had a small supply deal with Acambis which it expanded after 11 September last year as fears grew that terrorists could use smallpox as a biological weapon. It is now buying 209 million doses, enough to inoculate every citizen.
- 1 Sainsbury's '50p challenge' poster telling staff to encourage customers to spend more placed in shop window instead of staff room
- 2 Five-year-old Iris Grace is raising awareness of autism through her extraordinary paintings
- 3 HeForShe campaign: Iceland to follow up Emma Watson speech with UN women's rights conference – for men only
- 4 Car tax disc changes: Two days to go - and they affect you much more than just not displaying a piece of paper
- 5 Teenagers irritable because early school hours mess with their biological clocks
Five-year-old Iris Grace is raising awareness of autism through her extraordinary paintings
Car tax disc changes: Five facts you never knew about your (almost obsolete) tax disc
Isis an hour away from Baghdad - with no sign of Iraq army being able to make a successful counter-attack
Car tax disc changes: Two days to go - and they affect you much more than just not displaying a piece of paper
The Aral Sea: Nasa pictures show how what was once the fourth largest lake in the world has become almost completely dry
Isis, we are told, is a 'clear and dangerous threat to our way of life'. I’m sorry, but I just don’t buy it
Exclusive: 'Putin's Russia has been my biggest regret,' says Nato's outgoing Secretary General
The Osborne Ultimatum: Chancellor’s benefits freeze bombshell will affect ten million households
There’s no excuse for Dave Lee Travis’s behaviour, but we need to keep a sense of proportion
Should gay sex be illegal? 16% of Britons think so
Mark Reckless becomes second Tory MP to defect to Ukip in a month
- < Previous
- Next >
iJobs Money & Business
£18000 - £23000 per annum + Commission: SThree: Real Staffing are currently lo...
NEGOTIABLE: Austen Lloyd: TRUST ACCOUNTANT - KENTIf you are a Chartered Accou...
£18000 - £20000 per annum + OTE £30000: SThree: SThree are a global FTSE 250 b...
Highly Competitive Salary: Austen Lloyd: CITY - Law Costs Draftsperson - NICHE...